U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836128) titled 'The Combined Effect of N-Acetyl Cysteine and Metformin in Polycystic Ovary Syndrome Patients' on Jan. 30.
Brief Summary: The study aims to evaluate the effects of combination of metformin with NAC in PCOS on biochemical and hormonal parameters.
Study Start Date: Feb., 2025
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovary Syndrome
Intervention:
DRUG: N-acetyl cysteine
N-Acetyl Cysteine (NAC) has antioxidant properties and is essential for the body's production of glutathione, and both glutathione and NAC are potent antioxidants.
DRUG: Metfomin
metformin is commonly used for managing polycystic ovary syndrome (PCOS) due...